Influence of Bio-Oss Collagen Grafting at Implant Placement on Buccal Bone Volume Regeneration

NCT ID: NCT04338139

Last Updated: 2020-04-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-01-01

Study Completion Date

2021-07-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

to validate the capacity of bio-oss collagen (xenograft block+ collagen type I) placed solely without a membrane on a thin (0.5-1.8mm) buccal bone wall after delayed implant placement to regenerate bone volume. 30 patients requiring dental implants and presenting a deficient bone ridge (a ridge with reduced marginal bone width ≤ 2mm) were selected. The bone regeneration technique used in this study:

* Pre-operatively:

* cone beam computed tomography CBCT
* 1 minute mouthwash with a 0.12% Chlorhexidine solution
* Full thickness muco-periosteal flap and ridge curettage.
* Drilling and implant placement (any implant system)
* Adjustment and placement of the "Bio-Oss Collagen" in the regeneration site without a fixation membrane.
* Hermetic wound closure with U-shaped and simple stitches using 5/0 and 6/0 PGA resorbable material.
* Post-operatively:

* Medication:

* Amoxicilline (1g) or Clindamycine (300mg)
* Analgesic, (paracetamol + codeine)
* Mouthwash with a solution of 0.12% Chlorhexidine
* cone beam computed tomography CBCT

* 4 months postoperatively: CBCT

Bio-oss collagen is placed on the buccal side after implant placement and adapted to have the bone defect morphology. the full thickness flap is then closed without membrane placement and the bone bock is fixed in place through sutures only. CBCT images were taken immediately postoperatively and at 4 months after bone grafting. Imaging superposition (on ITK software) and measurements of buccal bone gain were effectuated to evaluate the efficiency of this regeneration technique. evaluation of buccal bone regeneration through linear radiographic measurements and evaluation of the % of grafted bone resorption will indicate the success of this technique

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Bone Regeneration

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Bio-oss Collagen

90% xengeneic bovine bone partciles + 10% collagen type I

Group Type EXPERIMENTAL

bone regeneration

Intervention Type PROCEDURE

bone regeneration using bio-oss collagen

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

bone regeneration

bone regeneration using bio-oss collagen

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age \>18 years old
* Smoking \<10 cigarettes/day (Light smoker)
* Good general health.
* Absence of acute infection: edema, suppuration, abscess, spontaneous bleeding.

Exclusion Criteria

* A pregnant or nursing mother
* Pathologies that may impair bone healing: diabetes, autoimmune diseases, corticosteroids, chemotherapy.

Orthodontic treatment in progress or planned

\- Adjacent risk teeth
Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Saint-Joseph University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Saint-Joseph University

Beirut, , Lebanon

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Lebanon

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

USJ-2019-112

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.